Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis

World Journal of Gastroenterology

Volumn 10, Issue 1, 2004, Pages 86-90

  Nie, Qing He ^a   Duan, Guo Rong ^a   Luo, Xin Dong ^a   Xie, Yu Mei ^a   Luo, Hong ^a   Zhou, Yong Xing ^a   Pan, Bo Rong ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; HUMAN SERUM ALBUMIN; LIVER ANTIGEN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROBLAST; GENE EXPRESSION; IMMUNITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL NUCLEUS; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0346685836     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i1.86     Document Type: Article

References (47)

1. Nie QH, Li MD, Hu DR, Chen GZ. Study on the cause of human protective immunodeficiency after HCV infection. Shijie Huaren Xiaohua Zazhi 2000; 8: 28-30
2. Dai YM, Shou ZP, Ni CR, Wang NJ, Zhang SP. Localization of HCV RNA and capsid protein in human hepatocellular carcinoma. World J Gastroenterol 2000; 6: 136-137
3. Wang Y, Liu H, Zhou Q, Li X. Analysis of point mutation in site 1896 of HBV precore and its detection in the tissues and serum of HCC patients. World J Gastroenterol 2000; 6: 395-397
4. Hu YP, Yao YC, Li JX, Wang XM, Li H, Wang ZH, Lei ZH. The cloning of 3′truncated preS/?S gene from HBV genomic DNA and its expression in transgenic mice. World J Gastroenterol 2000; 6: 734-737
5. Wen SJ, Xiang KJ, Huang ZH, Zhou R, Qi XZ. Construction of HBV specific ribozyme and its recombinant with HDV and their cleavage activity in vitro. World J Gastroenterol 2000; 6: 377-380
6. Nie QH, Li L, Li MD, Hu DR, Zhu YH, Chen GZ. Clinical and immunopathological studies in GBV-B infection. Shijie Huaren Xiaohua Zazhi 2000; 8: 775-781
7. Wang FS, Wu ZZ. Current situation in studies of gene therapy for liver cirrhosis and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 371-373
8. Wang GQ, Kong XT. Action of cell factor and Decorin in tissue fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 458-460
9. Liu F, Wang XM, Liu JX, Wei MX. Relationship between serum TGFβ1 of chronic hepatitis B and hepatic tissue pathology and hepatic fibrosis quantity. Shijie Huaren Xiaohua Zazhi 2000; 8: 528-531
10. Yao XX. Diagnosis and treatment of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 681-689
11. Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 2001; 5: 315-334
12. Sherker AH, Senosier M, Kermack D. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin. Hepatology 2003; 37: 223
13. Han HL, Lang ZW. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World J Gastroenterol 2003; 9: 117-121
14. 4. World J Gastroenterol 2003; 9: 539-543
15. Jiang HQ, Zhang XL. Mechanism of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 687-689
16. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21: 351-372
17. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA. Regulation of hepatic fibrosis and extracellular matrix genes by the th response: New insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 2001; 167: 7017-7026
18. 4. World J Gastroenterol 2000; 6: 824-828
19. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21: 351-372
20. Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta (1) in cystic fibrosis liver disease. Am J Pathol 2002; 160: 1705-1715
21. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-384
22. Liu YK, Shen W. Effect of Cordyceps sinensis on hepatocytic proliferation of experimental hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2002; 10: 388-391
23. Qin JP, Jiang MD. Phenotype and regulation of hepatic stellate cells and liver fibrosis. Shijie Huaren Xiaohua Zazhi 2001; 9: 801-804
24. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000; 32: 1248-1254
25. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis. J Biol Chem 2002; 277: 11069-11076
26. Dudas J, Kovalszky I, Gallai M, Nagy JO, Schaff Z, Knittel T, Mehde M, Neubauer K, Szalay F, Ramadori G. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol 2001; 115: 725-735
27. Nie QH, Cheng YQ, Xie YM, Zhou YX, Bai XG, Cao YZ. Methodologic research on TIMP-1,TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance. World J Gastroenterol 2002; 8: 282-287
28. Nie QH, Cheng YQ, Xie YM, Zhou YX, Cao YZ. Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis. World J Gastroenterol 2001; 7: 363-369
29. Wang BE, Wang ZF, Ying WY, Huang SF, Li JJ. The study on animal model of experimental liver fibrosis. Zhonghua Yixue Zazhi 1989; 69: 503-505
30. Nie QH, Hu DR, Li MD, Xie Q. The expression of HGV/GBV-C or HCV related antigens in the liver tissue of patients coinfected with hepatitis C and G viruses. Shijie Huaren Xiaohua Zazhi 2000; 8: 114-115
31. Nie QH, Li MD, Hu DR, Li L. The expression of hepatitis G virus-related antigens in the liver tissues of with hepatitis patients. Zhonghua Chuanranbing Zazhi 2000; 18: 173-175
32. Nie QH, Zhou YX, Xie YM. Expression and significance of tissue inhibitors of metalloproteinase-1 and -2 in serum and liver tissue of patients with liver cirrhosis. Zhonghua Yixue Zazhi 2001; 81: 805-807
33. Xie YM, Nie QH, Zhou YX, Cheng YQ, Kang WZ, Zhao YL. Tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1 and TIMP-2) mRNA and antigens location in the liver of patients with cirrhosis. Zhonghua Chuanranbing Zazhi 2001; 19: 352-354
34. Nie QH, Hu DR, Li MD, Li L, Zhu YH. Detection of hepatitis G virus RNA in liver tissue using digoxigenin labelled probe by in situ hybridization. Shijie Huaren Xiaohua Zazhi 2000; 8: 771-774
35. Okada A, Garnier JM, Vicaire S, Basset P. Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues. Gene 1994; 147: 301-302
36. Paronetto F, Popper H. Chronic liver injury induced by immunologic reactions. Cirrhosis following immunization with heterologous sera. Am J Pathol 1966; 49: 1087-1101
37. Flisiak R, Maxwell P, Prokopowicz D. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1 - Possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology 2002; 49: 1369-1372
38. Roeb E, Purucker E, Breuer B, Nguyen H, Heinrich PC, Rose-John S, Matern S. TIMP expression in toxic and cholestatic liver injury in rat. J Hepatol 1997; 27: 535-544
39. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, Clark N, Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996; 24: 176-184
40. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-384
41. Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta (1) in cystic fibrosis liver disease. Am J Pathol 2002; 160: 1705-1715
42. Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003; 37: 653-664
43. Liu YK, Shen W. Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. World J Gastroenterol 2003; 9: 529-533
44. Lamireau T, Desmouliere A, Bioulac-Sage P, Rosenbaum J. Mechanisms of hepatic fibrogenesis. Arch Pediatr 2002; 9: 392-405
45. Brenner DA, Waterboer T, Sung Kyu Choi, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A, Rippe RA New aspects of hepatic fibrosis. J Hepatol 2000; 32(Suppl 1): 32-38
46. De Lorenzo MS, Ripoll GV, Yoshiji H, Yamazaki M, Thorgeirsson UP, Alonso DF, Gomez DE. Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1. In Vivo 2003; 17: 45-50
47. Liu WB, Yang CQ, Jiang W, Wang YQ, Guo JS, He BM, Wang JY. Inhibition on the production of collagen type I,III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. World J Gastroenterol 2003; 9: 316-319